S'identifier

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

9.0K Views

09:24 min

June 9th, 2016

DOI :

10.3791/54026-v

June 9th, 2016

8,971 Views

Transcription

Explorer plus de vidéos

3D Biogel Culture
article

Now Playing

09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

9.0K Views

article

11:54

Identification and Isolation of Slow-Dividing Cells in Human Glioblastoma Using Carboxy Fluorescein Succinimidyl Ester (CFSE)

Vidéos connexes

14.0K Views

article

14:52

Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods

Vidéos connexes

26.2K Views

article

12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Vidéos connexes

21.1K Views

article

08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Vidéos connexes

14.0K Views

article

10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Vidéos connexes

10.9K Views

article

11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Vidéos connexes

10.7K Views

article

05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Vidéos connexes

9.0K Views

article

07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Vidéos connexes

18.9K Views

article

07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Vidéos connexes

8.2K Views

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.